The effect of the calcium antagonist nimodipine was tested in anaesthetised primates. A rapid intravenous injection of 3 or 10 f-Lg kg-1 pro duced a transient rise in end-tidal PC02 and a fall in arterial blood pressure, but 10 min after the injection there was no significant change in CBF. A continuous intravenous infusion of 2 f-Lg kg-1 min-1 caused a modest fall in mean arterial blood pressure and an increase in cerebral blood flow (CBF), which gradually
increased to 27% above control after 50 min infusion. There was no significant change in CMR02• A continuous intracarotid infusion of 0.67 f-Lg kg-1 min-1 caused an increase in CBF of between 46 and 57%. This was further increased to 87% above control after disruption of the blood-brain barrier with hyperos molar urea. Thirty minutes after the urea, the CBF returned to 43% above control. Twenty minutes after the infusion of nimodipine had been stopped, the CBF had returned to control values. EEG studies in this group showed no obvious increase in electrocortical activity. This evidence suggests that nimodipine has no effect on cerebral metabolism but increases CBF, particu larly after disruption of the blood-brain barrier. Key Words: Cerebral blood flow-Cerebral metabolism-Calcium antagonist-Nimodipine.
The ideal cerebral vasodilator would be a sub stance meeting the following criteria: firstly, a lim ited action on normal cerebral vessels in order to prevent "steal" phenomena in which dilatation of cerebral vessels can divert blood away from isch aemic areas; secondly, either no effect or a depress ant effect on cerebral metabolism; and thirdly, a predisposition to dilate vessels in or around isch aemic areas and vessels in spasm. These studies were designed to see how far the calcium antagonist nimodipine [BAY e 9736, isopropyl (2-methoxy ethyl) 1,4-dihydro-2,6-dimethyl-4(3-nitrophenyl)-3 ,5-pyridimedicarboxylate] met these criteria.
METHODS
The experiments were performed on baboons (Papio anubis or cynocephalus) 8.3 ± 2.0 kg (mean ± SD). Following sedation with phencyclidine (10 mg, i.m.), the animals were anaesthetised with in travenous sodium thiopental (7.5 mg/kg). They were intubated and connected to a positive-pressure ventilator delivering 70% nitrous oxide and oxygen in open circuit. A continuous intravenous infusion of phencyclidine, 0.0 1 mg kg-1 min-1, was given throughout the course of the experiment. Suxame thonium (50 mg, i.m.) was administered every 30 min in order to assist control of ventilation with the respiratory pump. Depth of anaesthesia was gauged by the absence of pupillary reflexes, a lack of pres sor response following noxious stimuli, and, in some animals, by the electroencephalographic (EEG) pattern.
During the experiments the end-tidal concentra tion of CO2 was continuously measured and the ventilatory pump adjusted to maintain an arterial carbon dioxide tension (PaC02) of between 37 and 40 mm Hg. Arterial blood samples were taken during every measurement of cerebral blood flow (CBF) to measure Paco2, Pao2, and pH by direct-reading electrodes (Corning). Body temperature was main tained around 37°C by means of an electrically heated blanket and infra-red heating lamps.
Catheters were inserted into the aorta via both femoral arteries for the continuous measurement of arterial blood pressure and for the withdrawal of arterial blood samples. Both femoral veins were cannulated, one for the continuous infusion of phencyclidine and the other for the infusion of nimodipine when appropriate.
A catheter was inserted into the right lingual ar tery so that its tip lay just distal to the carotid bifur cation. The other branches of the external carotid artery were tied, with the exception that in 4 animals the main branch of the external carotid ar tery was cannulated retrogradely to allow intraca rotid infusion of nimodipine. In some animals a small trephine hole was made over the midline fis sure and a fine catheter inserted into the sagittal sinus for the withdrawal of cerebral venous blood samples. The hole was sealed with plaster of Paris.
The scalp and temporalis muscle were removed with diathermy down to the level of the zygomatic arch.
Measurement of CBF and Cerebral

Oxygen Utilisation (CMR02)
A collimated scintillation crystal of the dimen sions and area of view shown in Fig. 1 was placed over the temporoparietal region of the exposed skull on the right side and angled in such a way that it viewed only the brain and overlying skull.
Approximately 250 /-LCi of xenon-133 dissolved in 0.5 ml sterile heparinised saline was injected over 1 s into the catheter in the lingual branch of the ca rotid artery. The gamma-ray emissions of the 133Xe were detected by the scintillation crystal attached to a photomultiplier. The pulses were amplified and subjected to pulse-height analysis (peak 81 ± 8 Ke V) to reduce Compton scatter before being fed into a ratemeter and scaler. The output from the rate meter was displayed on a chart recorder. CBF 
where F is the CBF (in ml blood/iOO g brain tissue/ min); A is the brain tissue/blood partition coefficient for 133Xe [the value from Veall and Mallett (1965) of 1. 1 was used for this study]; Hi, the maximum initial height of the 133Xe clearance curve in counts per second (cps) as taken from the chart recorder; H I O, the height of the clearance curve 10 min after the peak height in cps; A 1 0, the total integrated counts over the 10 min of clearance as taken from the scaler and corrected for background activity over that period.
Cerebral oxygen consumption was measured from the product of the CBF and the difference in oxygen content between the arterial blood and ce rebral venous blood sampled from the sagittal sinus. Blood oxygen content was measured by a charcoal-fuel cell system (Lex-02-Con).
EEG Recording
In some animals the EEG was recorded bilater ally throughout the experiment. A series of burr holes was drilled in the calvarium, 10 mm apart in two rows. Each row was 14 mm lateral to the sagit tal suture. The holes were threaded to receive nylon screws in which silver-silver chloride ball elec trodes were fixed loosely. The electrodes were po-sitioned epidurally, and the free ends were soldered to a multichannel socket which was mounted with plaster of Paris on the calvarium. The montage of the recording electrodes is shown in Fig. 5 . The technique is similar to that described by Brierley and his colleagues (1969) .
Osmotic Opening of the Blood-Brain Barrier
The tight junctions between adjacent endothelial cells of the cerebral arterioles and capillaries may be opened for periods of up to 30 min by a single intracarotid infusion of a hypertonic solution (Rapoport, 1970) . In some animals the technique for opening the blood-brain barrier by means of an intracarotid injection of hypertonic urea was used (MacKenzie et aI., 1976; Pickard et aI., 1977) . Ten millilitres of filtered urea solution (2 M) was injected over 15 s into the internal carotid artery via the catheter in the lingual artery. The pressure in the catheter during injection was held at approximately 15 mm Hg above MABP.
Preparation of Nimodipine
As the substance is very sensitive to light of nor mal wavelengths, nimodipine was dispensed under sodium light. The powder, solutions, catheters, and syringes for injection were always covered in silver foil. Ten milligrams of the drug was dissolved in 10 ml of Lutrol-glycerine-water solvent. It was heated gently with continuous stirring until fully dissolved. The solution was given undiluted for the animals in Group 1. In Group 2, for the average 8.3-kg baboon, the stock solution was diluted approximately 24fold with normal saline for continuous intravenous infusion and 36-fold for the intracarotid infusions (Group 3).
Experimental Protocol
Following completion of the surgery, the animals were left undisturbed for I h. At least 3 control estimations of CBF and the other parameters were made until steady conditions of flow, arterial blood pressure, and blood gas tensions were obtained.
In Group 1 (n = 3), nimodipine was injected in travenously over 30 s at a dose of 3 /J-g kg-l followed by a further rapid injection of 10 /J-g kg-I.
In Group 2 (n = 5), nimodipine solution 2 /J-g kg-l min-I, was infused at a rate of 0.4 mllmin into the femoral venous catheter. In 4 animals in this group, cerebral venous samples were taken from the sagittal sinus for determination of CMR02•
In control experiments for Group 3, a 1:30 solu tion of Lutrol in saline was infused into the carotid artery at a rate of 0.2 mllmin. There were no signifi cant changes in CBF, MABP, or Paco2 at 10 or 30 min after commencing the infusion. In the definitive experiments in 4 animals, 0.67 /J-g kg-l min-l of nimodipine solution was infused at a rate of 0.2 mllmin into the catheter inserted through the exter nal carotid catheter centrifugally into the carotid bifurcation. EEG studies were performed in 3 animals in this group. Following control estima tions, nimodipine infusion was commenced as CBF was measured at 10 and 30 min. Intracarotid urea was then given as described previously and CBF again measured 10 and 30 min after the urea infu sion. During this period, nimodipine was continu ously infused into the carotid artery. Final mea surements were made approximately 20 min after stopping the infusion. " " " " * 1 * 1 
RESULTS
Group 1: rapid intravenous injection over 30 s of 3 and 10 p,g kg-I . The immediate response was a rise in end-tidal Pco2 and a fall in MABP (Fig. 2) . This lasted only a few minutes. Ten minutes after the injection of either dose, the BP and PaC02 had returned to control values (101 and 39 mm Hg; re spectively), and there was no significant change in CBF (62 ml 100 g-I min-I to 64 ml for the 3 fJ-g kg-I dose, and 62 ml to exactly the same value for the 10 fJ-g kg-I dose). Group 2: Intravenous nimodipine (2 p,g kg-I min-I). The results are shown in Fig. 3 and Table 1 .
After between 30 and 50 min infusion, there was an increase in CBF of between 19 and 27%. This is significantly different from control. There was a drop in MABP of between 12 and 8%.
There were no significant differences in CMR02 or Paco2 during the infusion. Group 3: intracarotid nimodipine (0.67 p,g kg-I min-I). The results are shown in Fig. 4 and Table 2 . After between 10 and 30 min infusion, there was a significant increase in CBF of between 46 and 57%. Ten minutes after disruption of the blood brain barrier, the increase in flow was 87%. This was significantly different from the infusion of nimodipine alone (p < 0.01). Thirty minutes after urea, when it is expected that the barrier would have closed again, the increase in flow with con tinued infusion of nimodipine had returned to 43%. On stopping the infusion, CBF had returned to ap proximately control values after 20 min.
In the 3 animals in whom EEG studies were made, there was no obvious increase in electrocor tical activity (see Fig. 5 for an example). In this figure the CBF during the control EEG was 62 ml 100 g-l min-I, and during the intracarotid infusion, 109 ml 100 g-I min-I. 
DISCUSSION
Calcium antagonists differ in their modes of ac tion, but all decrease the amount of activator cal cium in the smooth muscle cytoplasm and thereby cause vasodilatation. This may be achieved by blocking calcium entry at the cell membrane and/or by inhibiting the release of intracellularly stored calcium (e.g., calcium stored in the sarcoplasmic reticulum). Such drugs are direct vasodilators (Van Nueten and Wellens, 1979) . Nimodipine has been shown to be a potent inhibitor of calcium ion influx into isolated peripheral and cerebral vascular smooth muscle (Tow art and . How ever, there appear to be differences in the relative sensitivities of cerebral and peripheral vascular smooth muscle to the drug. The need for external calcium for contraction varies among the different types of blood vessels and is possibly due to differ ences in the amounts of endoplasmic reticulum and sarcoplasmic reticulum (structures involved in the storage and release of activator calcium) in the smooth muscle (Devine et aI., 1972) . It has been shown that pathological spasm of cerebral vascula ture is more dependent on extracellular calcium than is tone of peripheral vessels (Allen and Bang hart, 1979) . Serotonin-induced contractions of iso lated rabbit basilar artery were reduced in a dose- dependent manner by the drug, while those of iso lated rabbit saphenous artery were unaffected even at high doses (Towart and Kazda, 1980) , suggesting that cerebral vessels may be affected more than others. Indeed, a notable feature of this drug is its lack of generalised systemic effects. In an earlier study in the cat, it was noted that over a wide dose range, BP did not change (Kazda et aI., 1979) . In the present experiments, however, there was a drop in BP of approximately 10 mm Hg during intravenous infu sion of nimodipine.
Modest increases in CBF were obtained during intravenous infusion of nimodipine. However, when the drug was infused into the carotid artery following disruption of the blood-brain barrier with hypertonic urea, very marked increases in flow (about 90%) were produced. Infusion of urea itself has only a transient effect on BP and saggital sinus pressure, which subsides 5 min after administration. It was found to have no effect on CBF, CMR02, or intracranial pressure when these variables were measured 5 -10 min after urea (Pickard et aI., 1977) .
It is important to note that no significant changes in either cerebral oxygen uptake or EEG were re corded during the infusion of nimodipine. This suggests that the drug has little effect on cerebral metabolism. the blood-brain barrier, it could well be clinically useful in preferentially increasing flow to areas of the brain where the barrier has been damaged fol lowing head injury or cerebrovascular accident.
